KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 189 filers reported holding KRYSTAL BIOTECH INC in Q3 2023. The put-call ratio across all filers is 1.12 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $30,419,144 | +71.8% | 262,234 | +73.9% | 0.01% | +83.3% |
Q2 2023 | $17,708,498 | +417750.4% | 150,839 | +185.0% | 0.01% | +200.0% |
Q1 2023 | $4,238 | -6.8% | 52,931 | -7.8% | 0.00% | 0.0% |
Q4 2022 | $4,548 | -99.9% | 57,412 | -32.7% | 0.00% | 0.0% |
Q3 2022 | $5,947,000 | +6.1% | 85,325 | -0.0% | 0.00% | 0.0% |
Q2 2022 | $5,604,000 | -0.7% | 85,356 | +1.3% | 0.00% | 0.0% |
Q1 2022 | $5,644,000 | +3.2% | 84,259 | +7.8% | 0.00% | 0.0% |
Q4 2021 | $5,468,000 | +27.3% | 78,178 | -5.0% | 0.00% | +100.0% |
Q3 2021 | $4,297,000 | -7.4% | 82,300 | +20.7% | 0.00% | 0.0% |
Q2 2021 | $4,638,000 | +15.1% | 68,210 | +30.4% | 0.00% | 0.0% |
Q1 2021 | $4,029,000 | +39.4% | 52,296 | +8.5% | 0.00% | 0.0% |
Q4 2020 | $2,891,000 | +43.0% | 48,191 | +2.6% | 0.00% | 0.0% |
Q3 2020 | $2,022,000 | +10.4% | 46,974 | +6.3% | 0.00% | 0.0% |
Q2 2020 | $1,831,000 | +1.6% | 44,200 | +6.1% | 0.00% | 0.0% |
Q1 2020 | $1,802,000 | -17.6% | 41,676 | +5.5% | 0.00% | 0.0% |
Q4 2019 | $2,187,000 | +55.0% | 39,487 | -2.8% | 0.00% | 0.0% |
Q3 2019 | $1,411,000 | -0.4% | 40,632 | +15.5% | 0.00% | 0.0% |
Q2 2019 | $1,417,000 | – | 35,182 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FRAZIER MANAGEMENT LLC | 771,250 | $53,949,000 | 4.15% |
First Light Asset Management, LLC | 680,170 | $47,578,000 | 3.41% |
ACT CAPITAL MANAGEMENT, LLC | 59,000 | $4,127,000 | 2.98% |
S Squared Technology, LLC | 95,215 | $6,660,000 | 2.98% |
Redmile Group, LLC | 1,820,898 | $127,372,000 | 2.90% |
Soleus Capital Management, L.P. | 228,437 | $15,979,000 | 1.60% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 50,922 | $3,562,000 | 1.59% |
Artal Group S.A. | 700,000 | $48,965,000 | 1.33% |
SILVERARC CAPITAL MANAGEMENT, LLC | 46,670 | $3,265,000 | 1.32% |
Kynam Capital Management, LP | 34,816 | $2,435,000 | 1.30% |